CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 9, 2022 · earnings

KROS earnings: a positive outcome, +7.7%

On March 9, 2022, Keros Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.7% in the window around the event.

The move

$50.08
1d before
$53.96
Event day
$54.42
1d after
$48.33
5d after

Pre-catalyst setup

-4.4%
30-day run-up
6493%
30-day volatility
1.0×
volume spike